Li-Zhu Wei Oscar Jie, Inés Jiménez Viseu-Pinheiro, Christian Aram Alcalá Tsouroukdissian, Marta Rueda Herrera, Silvia Álvarez Kailis, R. G. Carretero, Andrea Pérez Rodríguez, María Augusta Guillén-Sacoto
{"title":"1615 - 对 2 型糖尿病患者从头开始使用塞马鲁肽皮下制剂或口服制剂的实际对比研究:两者的耐受性是否相同?","authors":"Li-Zhu Wei Oscar Jie, Inés Jiménez Viseu-Pinheiro, Christian Aram Alcalá Tsouroukdissian, Marta Rueda Herrera, Silvia Álvarez Kailis, R. G. Carretero, Andrea Pérez Rodríguez, María Augusta Guillén-Sacoto","doi":"10.1016/s0014-2565(23)00722-1","DOIUrl":null,"url":null,"abstract":"","PeriodicalId":369727,"journal":{"name":"Revista Clínica Española","volume":"50 1","pages":""},"PeriodicalIF":0.0000,"publicationDate":"2023-11-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"1615 - ESTUDIO COMPARATIVO EN VIDA REAL DEL USO DE SEMAGLUTIDA EN FORMULACIÓN SUBCUTÁNEA U ORAL INICIADA DE NOVO EN PACIENTES CON DIABETES TIPO 2: ¿SE TOLERAN IGUAL?\",\"authors\":\"Li-Zhu Wei Oscar Jie, Inés Jiménez Viseu-Pinheiro, Christian Aram Alcalá Tsouroukdissian, Marta Rueda Herrera, Silvia Álvarez Kailis, R. G. Carretero, Andrea Pérez Rodríguez, María Augusta Guillén-Sacoto\",\"doi\":\"10.1016/s0014-2565(23)00722-1\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"\",\"PeriodicalId\":369727,\"journal\":{\"name\":\"Revista Clínica Española\",\"volume\":\"50 1\",\"pages\":\"\"},\"PeriodicalIF\":0.0000,\"publicationDate\":\"2023-11-01\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Revista Clínica Española\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.1016/s0014-2565(23)00722-1\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"\",\"JCRName\":\"\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Revista Clínica Española","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1016/s0014-2565(23)00722-1","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
1615 - ESTUDIO COMPARATIVO EN VIDA REAL DEL USO DE SEMAGLUTIDA EN FORMULACIÓN SUBCUTÁNEA U ORAL INICIADA DE NOVO EN PACIENTES CON DIABETES TIPO 2: ¿SE TOLERAN IGUAL?